Laura Bentz of Keybridge Communications describes her company as a boutique PR firm—founded by a former writer for the Wall Street Journal—that specializes in writing and placing op-eds. With some of the country’s most influential trade groups and global corporations as clients, we run many of the major op-ed campaigns in the US. We place roughly 3,000 op-eds per year.

“Under Fire, Mylan to Offer Generic EpiPen for 50% Less,” was USA Today‘s headline (8/29/16). That depends on when you start the clock. The drug-maker announced that it would be selling an unbranded version of the lifesaving anti-allergy device for $300 for a two-pack.  That’s actually a little more than a 50 percent reduction from the current list price; a two-pack of EpiPens generally sells for $608.

When Hillary Clinton and Donald Trump address the American Legion’s upcoming national convention,  they will no doubt explain why they are the right choice to be the next commander-in-chief.

  This week on CounterSpin: For months now, hundreds and then thousands of indigenous people have been taking part in peaceful protests at the Sacred Stones camp in North Dakota. They’re protesting the construction of what’s called the Dakota Access pipeline, slated to carry fracked oil across the state and across the Missouri River. The Standing Rock Sioux say the Army Corps of Engineers approved the pipeline without their consent. For many people, what’s happening right now in North Dakota is a crucial story of a frontline fight of indigenous people against extractive industry—and on behalf of humanity, really, and the planet.